256 related articles for article (PubMed ID: 36965240)
1. Possible role of nutrition in the prevention of inflammatory bowel disease-related colorectal cancer: A focus on human studies.
Cassotta M; Cianciosi D; De Giuseppe R; Navarro-Hortal MD; Armas Diaz Y; Forbes-Hernández TY; Pifarre KT; Pascual Barrera AE; Grosso G; Xiao J; Battino M; Giampieri F
Nutrition; 2023 Jun; 110():111980. PubMed ID: 36965240
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
Kim ER; Chang DK
World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in inflammatory bowel disease: review of the evidence.
Keller DS; Windsor A; Cohen R; Chand M
Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
[TBL] [Abstract][Full Text] [Related]
6. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
7. Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.
Ma Y; Zhang Y; Xiang J; Xiang S; Zhao Y; Xiao M; Du F; Ji H; Kaboli PJ; Wu X; Li M; Wen Q; Shen J; Yang Z; Li J; Xiao Z
Front Cell Infect Microbiol; 2021; 11():599734. PubMed ID: 33738265
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease and carcinogenesis.
Nagao-Kitamoto H; Kitamoto S; Kamada N
Cancer Metastasis Rev; 2022 Jun; 41(2):301-316. PubMed ID: 35416564
[TBL] [Abstract][Full Text] [Related]
9. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies.
Fantini MC; Guadagni I
Dig Liver Dis; 2021 May; 53(5):558-565. PubMed ID: 33541800
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
Herszényi L; Barabás L; Miheller P; Tulassay Z
Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
[TBL] [Abstract][Full Text] [Related]
11. The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival.
Vitali F; Wein A; Rath T; Eckstein M; Neufert C; Siebler J; Atreya R; Hartmann A; Hohenberger W; Weber K; Neurath MF; Grützmann R; Merkel S
Int J Colorectal Dis; 2022 Feb; 37(2):381-391. PubMed ID: 34865179
[TBL] [Abstract][Full Text] [Related]
12. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
Kang M; Martin A
Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
[TBL] [Abstract][Full Text] [Related]
13. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
14. Temporal trend in inpatient mortality in inflammatory bowel disease-associated colorectal cancer vs non-inflammatory colorectal cancer: a nationwide retrospective study.
Flores E; Mbachi C; Achebe I; Asotibe J; Palomera-Tejeda E; Vohra I; Udechukwu V; Kotwal V
Int J Colorectal Dis; 2021 Apr; 36(4):701-708. PubMed ID: 33063223
[TBL] [Abstract][Full Text] [Related]
15. Dysplasia and cancer in inflammatory bowel disease.
Basseri RJ; Basseri B; Papadakis KA
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
[TBL] [Abstract][Full Text] [Related]
16. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
[TBL] [Abstract][Full Text] [Related]
17. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
18. Possible Molecular Mechanisms by which Vitamin D Prevents Inflammatory Bowel Disease and Colitis-associated Colorectal Cancer.
Luan Z; Ma Y; Xin Y; Qian J; Wang H
Curr Med Chem; 2017; 24(9):911-917. PubMed ID: 27915990
[TBL] [Abstract][Full Text] [Related]
19. Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
de Krijger M; Carvalho B; Rausch C; Bolijn AS; Delis-van Diemen PM; Tijssen M; van Engeland M; Mostafavi N; Bogie RMM; Dekker E; Masclee AAM; Verheij J; Meijer GA; Ponsioen CY
Inflamm Bowel Dis; 2022 Sep; 28(9):1309-1320. PubMed ID: 35554535
[TBL] [Abstract][Full Text] [Related]
20. Influence of Foods and Nutrition on the Gut Microbiome and Implications for Intestinal Health.
Zhang P
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
